Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation.
de Boer EC, Thielen AJ, Langereis JD, Kamp A, Brouwer MC, Oskam N, Jongsma ML, Baral AJ, Spaapen RM, Zeerleder S, Vidarsson G, Rispens T, Wouters D, Pouw RB, Jongerius I. de Boer EC, et al. Clin Transl Immunology. 2023 Jan 27;12(1):e1436. doi: 10.1002/cti2.1436. eCollection 2023. Clin Transl Immunology. 2023. PMID: 36721662 Free PMC article.
The Influence of Human IgG Subclass and Allotype on Complement Activation.
Damelang T, de Taeye SW, Rentenaar R, Roya-Kouchaki K, de Boer E, Derksen NIL, van Kessel K, Lissenberg-Thunnissen S, Rooijakkers SHM, Jongerius I, Mebius MM, Schuurman J, Labrijn AF, Vidarsson G, Rispens T. Damelang T, et al. J Immunol. 2023 Dec 1;211(11):1725-1735. doi: 10.4049/jimmunol.2300307. J Immunol. 2023. PMID: 37843500 Free PMC article.
Ephrin-Eph signaling usage by a variety of viruses.
de Boer ECW, van Gils JM, van Gils MJ. de Boer ECW, et al. Pharmacol Res. 2020 Sep;159:105038. doi: 10.1016/j.phrs.2020.105038. Epub 2020 Jun 18. Pharmacol Res. 2020. PMID: 32565311 Free article. Review.
C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia.
de Boer ECW, Jalink M, Delvasto-Nuñez L, Meulenbroek EM, Baas I, Janssen SR, Folman CC, Gelderman KA, Wouters D, Engel MD, de Haas M, Kersten MJ, Jongerius I, Zeerleder S, Vos JMI. de Boer ECW, et al. Blood Adv. 2023 Jul 11;7(13):3128-3139. doi: 10.1182/bloodadvances.2022009402. Blood Adv. 2023. PMID: 36920779 Free PMC article. Clinical Trial.